68 related articles for article (PubMed ID: 12497044)
1. Detection of preneoplasia in histologically normal prostate biopsies.
Slater MD; Delprado WJ; Murphy CR; Barden JA
Prostate Cancer Prostatic Dis; 2001; 4(2):92-96. PubMed ID: 12497044
[TBL] [Abstract][Full Text] [Related]
2. Markers for the development of early prostate cancer.
Slater MD; Lauer C; Gidley-Baird A; Barden JA
J Pathol; 2003 Mar; 199(3):368-77. PubMed ID: 12579539
[TBL] [Abstract][Full Text] [Related]
3. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
4. Expression of the apoptotic calcium channel P2X7 in the glandular epithelium.
Slater M; Danieletto S; Barden JA
J Mol Histol; 2005 Mar; 36(3):159-65. PubMed ID: 15900405
[TBL] [Abstract][Full Text] [Related]
5. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
6. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
7. High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon.
Angwafo FF; Zaher A; Befidi-Mengue R; Wonkam A; Takougang I; Powell I; Murphy G;
Prostate Cancer Prostatic Dis; 2003; 6(1):34-8. PubMed ID: 12664062
[TBL] [Abstract][Full Text] [Related]
8. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
10. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
11. [Biopsy technique and biopsy schemes for a first series of prostatic biopsies].
Villers A; Mouton D; Rébillard X; Chautard D; Ruffion A; Staerman F; Cornud F
Prog Urol; 2004 Apr; 14(2):144-53. PubMed ID: 15217126
[TBL] [Abstract][Full Text] [Related]
12. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I
Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692
[TBL] [Abstract][Full Text] [Related]
13. Number and location of nucleoli and presence of apoptotic bodies in diagnostically challenging cases of prostate adenocarcinoma on needle biopsy.
Aydin H; Zhou M; Herawi M; Epstein JI
Hum Pathol; 2005 Nov; 36(11):1172-7. PubMed ID: 16260270
[TBL] [Abstract][Full Text] [Related]
14. Bax and Bcl-2 are focally overexpressed in the normal epithelium of cancerous prostates.
Tolonen TT; Tommola S; Jokinen S; Parviainen T; Martikainen PM
Scand J Urol Nephrol; 2007; 41(2):85-90. PubMed ID: 17454944
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
[TBL] [Abstract][Full Text] [Related]
16. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
17. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population.
Steiner H; Moser P; Hager M; Berger AP; Klocker H; Spranger R; Rogatsch H; Bartsch G; Horninger W
Prostate; 2004 Feb; 58(3):277-82. PubMed ID: 14743467
[TBL] [Abstract][Full Text] [Related]
19. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
